The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but recent findings indicate an elevated risk of severe disease among vaccinees without prior dengue virus (DENV) exposure. The World Health Organization currently recommends CYD-TDV only for individuals with serological confirmation of past DENV exposure. Our objective was to evaluate the potential health impact and cost-effectiveness of vaccination following serological screening. To do so, we used an agent-based model to simulate DENV transmission with and without vaccination over a 10-year timeframe. Across a range of values for the proportion of vaccinees with prior DENV exposure, we projected the proportion of symptomatic and hospitalized ...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
AbstractIn response to the sharp rise in the global burden caused by dengue virus (DENV) over the la...
The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but...
The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but...
The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but...
, 2015, Mexico became the first country for which the dengue vaccine was approved for use. In antici...
BackgroundLarge Phase III trials across Asia and Latin America have recently demonstrated the effica...
BACKGROUND:The incidence of dengue fever (DF) is steadily increasing in Mexico, burdening health sys...
Background Large Phase III trials across Asia and Latin America have recently demonstrated the effic...
Large Phase III trials across Asia and Latin America have recently demonstrated the efficacy of a re...
In response to the sharp rise in the global burden caused by dengue virus (DENV) over the last few d...
In response to the sharp rise in the global burden caused by dengue virus (DENV) over the last few d...
In response to the sharp rise in the global burden caused by dengue virus (DENV) over the last few d...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
AbstractIn response to the sharp rise in the global burden caused by dengue virus (DENV) over the la...
The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but...
The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but...
The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but...
, 2015, Mexico became the first country for which the dengue vaccine was approved for use. In antici...
BackgroundLarge Phase III trials across Asia and Latin America have recently demonstrated the effica...
BACKGROUND:The incidence of dengue fever (DF) is steadily increasing in Mexico, burdening health sys...
Background Large Phase III trials across Asia and Latin America have recently demonstrated the effic...
Large Phase III trials across Asia and Latin America have recently demonstrated the efficacy of a re...
In response to the sharp rise in the global burden caused by dengue virus (DENV) over the last few d...
In response to the sharp rise in the global burden caused by dengue virus (DENV) over the last few d...
In response to the sharp rise in the global burden caused by dengue virus (DENV) over the last few d...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
AbstractIn response to the sharp rise in the global burden caused by dengue virus (DENV) over the la...